Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Wingard

Showing results (121-130 of 267) with videos related to

Pageof 27
Sort By:
Journal of Clinical Apheresis|May 31, 2017
Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantationJan S Moreb, Michael Byrne, Ilicia Shugarman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2004
Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignanciesCasey B Williams, Suzanne D Day, Michael D Reed, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2007
Umbilical cord blood produces small megakaryocytes after transplantationMark Ignatz, Martha Sola-Visner, Lisa M Rimsza, et al.
Leukemia & Lymphoma|June 6, 2024
A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemiaKriti Gera, Christina Cline, Zeina Al-Mansour, et al.
Diabetes Care|October 31, 2009
Autologous umbilical cord blood transfusion in very young children with type 1 diabetesMichael J Haller, Clive H Wasserfall, Kieran M McGrail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controlsMichelle M Bishop, Jennifer L Beaumont, Elizabeth A Hahn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2025
Plasma microbial cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High Risk Outpatient and Inpatient Immunocompromised HostsBeatrice Z Sim, Jordan K Mah, Madeleine R Heldman, et al.
Bone Marrow Transplantation|March 9, 2018
Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trialHeather S L Jim, Steven Sutton, Navneet S Majhail, et al.
The Lancet. Haematology|May 30, 2025
Beyond maximum grade: tolerability of immunotherapies, cellular therapies, and targeted agents in haematological malignanciesPaul J Bröckelmann, Edward R Scheffer Cliff, Gloria Iacoboni, et al.
Experimental Hematology|August 19, 2007
Sites and kinetics of donor thrombopoiesis following transplantation of whole bone marrow and progenitor subsetsXiao-Miao Li, Zhongbo Hu, Martha Sola-Visner, et al.
Pageof 27

Showing results (121-130 of 267) with videos related to

Sort By:
Pageof 27
Journal of Clinical Apheresis|May 31, 2017
Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantationJan S Moreb, Michael Byrne, Ilicia Shugarman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2004
Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignanciesCasey B Williams, Suzanne D Day, Michael D Reed, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2007
Umbilical cord blood produces small megakaryocytes after transplantationMark Ignatz, Martha Sola-Visner, Lisa M Rimsza, et al.
Leukemia & Lymphoma|June 6, 2024
A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemiaKriti Gera, Christina Cline, Zeina Al-Mansour, et al.
Diabetes Care|October 31, 2009
Autologous umbilical cord blood transfusion in very young children with type 1 diabetesMichael J Haller, Clive H Wasserfall, Kieran M McGrail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controlsMichelle M Bishop, Jennifer L Beaumont, Elizabeth A Hahn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2025
Plasma microbial cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High Risk Outpatient and Inpatient Immunocompromised HostsBeatrice Z Sim, Jordan K Mah, Madeleine R Heldman, et al.
Bone Marrow Transplantation|March 9, 2018
Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trialHeather S L Jim, Steven Sutton, Navneet S Majhail, et al.
The Lancet. Haematology|May 30, 2025
Beyond maximum grade: tolerability of immunotherapies, cellular therapies, and targeted agents in haematological malignanciesPaul J Bröckelmann, Edward R Scheffer Cliff, Gloria Iacoboni, et al.
Experimental Hematology|August 19, 2007
Sites and kinetics of donor thrombopoiesis following transplantation of whole bone marrow and progenitor subsetsXiao-Miao Li, Zhongbo Hu, Martha Sola-Visner, et al.
Pageof 27